Health
Immatics to Secure $125 Million from Share Offering
Biotech company Immatics (IMTX) has announced its plans to raise $125 million through a public offering of 12,500,000 ordinary shares. Each share is priced at $10.00, with the gross proceeds expected before deducting underwriting discounts and other related expenses. The offering is scheduled to close on December 8, 2025.
The share offering will be managed by a team of financial experts, including Jefferies, Leerink Partners, and Cantor, who are serving as joint book-running managers. This strategic move is aimed at strengthening the company’s financial position and supporting its ongoing projects in the biotechnology sector.
In premarket trading on Friday, shares of Immatics saw a decrease of 4%, reflecting market reactions to the announcement. The company’s stock performance will be closely monitored as the offering date approaches.
Immatics focuses on developing innovative T-cell receptor therapies for cancer treatment. The capital raised from this offering will potentially enhance its ability to advance research and development efforts, expand clinical trials, and bring new therapies to market.
Investors and analysts will be watching closely to see how this offering impacts Immatics’ position within the competitive biotech industry. The successful execution of this plan may pave the way for future growth and development in the company’s pipeline.
Meta Plans Major Layoffs as AI Costs Surge
Alberta’s Referendum Could Pave Way for U.S. Statehood
Minooka District 201 Plans Enhanced Bilingual Support for Students
Canmore Approves Multiple Development Permits for New Projects
Remembering Bradly Castillo Shearsmith: A Life of Friendship and Joy
BIS Urges Watchdogs to Integrate Synthetic Risk Transfers in Stress Tests
Teva Transforms: Shifting Focus from Generics to Branded Success
Apple Launches AirPods Max 2 with Enhanced Audio Features
Ontario Ends Funding for Seven Supervised Injection Sites
Toyoake City Proposes Daily Two-Hour Smartphone Use Limit
Pedestrian Fatally Injured in Esquimalt Collision on August 14
B.C. Review Reveals Urgent Need for Rare-Disease Drug Reforms
Dark Adventure Game “Bye Sweet Carole” Set for October Release
Konami Revives Iconic Metal Gear Solid Delta Ahead of Release
Victoria’s Pop-Up Shop Shines Light on B.C.’s Wolf Cull
Jimmy Lai’s Defense Challenges Charges Under National Security Law
Snapmaker U1 Color 3D Printer Redefines Speed and Sustainability
Apple Expands Self-Service Repair Program to Canada
-
Science11 months agoToyoake City Proposes Daily Two-Hour Smartphone Use Limit
-
Top Stories11 months agoPedestrian Fatally Injured in Esquimalt Collision on August 14
-
Health11 months agoB.C. Review Reveals Urgent Need for Rare-Disease Drug Reforms
-
Technology11 months agoDark Adventure Game “Bye Sweet Carole” Set for October Release
-
Technology11 months agoKonami Revives Iconic Metal Gear Solid Delta Ahead of Release
-
Lifestyle11 months agoVictoria’s Pop-Up Shop Shines Light on B.C.’s Wolf Cull
-
World11 months agoJimmy Lai’s Defense Challenges Charges Under National Security Law
-
Technology11 months agoSnapmaker U1 Color 3D Printer Redefines Speed and Sustainability
-
Technology11 months agoApple Expands Self-Service Repair Program to Canada
-
Technology11 months agoAION Folding Knife: Redefining EDC Design with Premium Materials
-
Technology11 months agoSolve Today’s Wordle Challenge: Hints and Answer for August 19
-
Business11 months agoGordon Murray Automotive Unveils S1 LM and Le Mans GTR at Monterey